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Abstract
Biodegradable–biocompatible polyurethanes were prepared with fixed hexamethylene 
diisocyanate and varying ratios of isomannide and poly(ε-caprolactone) diol using a simple 
one-step polymerization without a catalyst. The polyurethane structures were confirmed by 
1H-nuclear magnetic resonance, Fourier transform infrared spectroscopy, and gel permeation 
chromatography. The glass transition temperatures were determined by thermal analysis 
to be between 25°C and 30°C. Degradation tests performed at 37°C in phosphate buffer 
produced mass losses of 5%–10% after 8 weeks. After 5 days of culture, using osteoblastic 
cells, the relative cell number on all the polyurethane films was only slightly lower than that of 
an optimized tissue culture plastic. These polymers offer significant promise with a simplistic 
synthesis and controlled degradation.
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Introduction
Tissue engineering is the future medical treatment for reconstructing defective tissues over the last 
decade.1 Tissue regeneration is a relatively simple tissue engineering treatment compared with 
other treatments, such as in vitro tissue reconstruction; for example, in periodontitis, new tissue 
was reconstructed using a membrane to prevent other tissues from invading the affected areas.2 
Recently, tissue regeneration, and the biomaterials used in tissue regeneration, has undergone a 
significant expansion both academically and commercially.3
The major materials used in tissue regeneration are biodegradable polymers. Biodegradable 
polymers, with good biocompatibility, have significant potential in various tissue engineering and 
drug delivery fields.4 Virtually, all tissue engineering devices are implanted in a mechanically 
active site in the body; thus, these implants are subjected to dynamic stress; therefore, it is very 
important that the polymers do not physically degrade, as their by-products can cause inflamma-
tory effect to the surrounding tissues. Several families of biodegradable polymers have been devel-
oped, such as polyurethanes, poly(aliphatic esters), and poly(phosphate esters).5 These polymers 
have dominated the field as they are relatively cheap and they have Food and Drug Administration 
approval for clinical use.
Polyurethanes are a class of biodegradable polymers that have been applied as tissue engineer-
ing scaffolds as they show low in vitro and in vivo cytotoxicity.6 Polyurethanes created by reacting 
dialcohol with diisocyanate result in the highly hydrogen-bonded urethane linkages with good 
physical and mechanical properties and with the haemocompatibility and flexibility needed for use 
in biomedical applications.6 In fact, many non-biodegradable urethanes have been utilized in blood 
contact applications such as breast implants, aortic grafts, bone adhesives, dialysis membranes, and 
heart valves.6 Biodegradable polyurethanes can be obtained using biodegradable soft segments and 
isomannide hard segments. In the biodegradable soft segment, polyurethanes, such as those con-
taining poly(ε-caprolactone) (PCL), have been obtained7 along with poly(ethylene oxide) (PEO) 
and poly(L-lactide) PLA.8 In the biodegradable hard segments, the diisocyanate and the chain 
extender can be designed from a variety of biologically relevant molecules.
Several possibilities were considered to produce biodegradable polyurethanes. Biodegradable 
hard segments have been obtained with aliphatic diisocyanate, methylene lysine diisocyanate, and 
hexamethylene diisocyanate (HDI). Good examples of such raw materials are those produced from 
glucose as the natural feedstock.9 Isomannide is a promising material for biobased monomers as it is 
nontoxic and has appropriate chirality and bicyclic ring structure, which imparts rigidity.10 Isomannide 
has been used in various polymer systems such as polyester, polyether, and polyurethane.
In this study a polyurethane series was made with isomannide, PCL diol, and HDI compounds to 
satisfy the demands of tissue regeneration technology. Aliphatic diisocyanates are usually chosen to 
synthesize biocompatible and biodegradable polyurethanes because their degradation product is 
nontoxic. Polyester diols, such as PCL diol, are also chosen as they hydrolytically degrade to caproic 
acid. Isomannide was chosen as the dialcohol monomer for its chiral, rigid, and nontoxic properties. 
The typically polyurethanes are made in a two-step polymerization.11 However, a bulk, one-pot 
synthetic method without catalyst, was employed in this study.
Experimental section
Materials and instruments
Isomannide (98%) and HDI (99%) were purchased from Sigma–Aldrich (St Louis, MO, 
USA). PCL diol 2000 (CAPA 2201A; Mw = 2000) was purchased from Kangnam Chemical 
Co., Ltd (Seoul, South Korea), and phosphate-buffered saline (approximately pH 7.3) was 
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obtained from Oxoid Ltd (Hampshire, England). All chemicals were used without further 
purification.
Preparation of the polyurethanes
The monomers were mixed together and allowed to react.11 Synthesis was carried out in a 250 
mL round-bottomed four-neck flask with reactant stoichiometry of 1:1 with diisocyanate:diol 
(PCL diol and isomannide) under a dry nitrogen atmosphere. A nitrogen flushed four-neck flask 
equipped with a mechanical stirrer, thermometer, and condenser was charged with 12.5 mmol of 
PCL diol (25 g) and 12.5 mmol of isomannide (41.83 g) (reactant stoichiometry and precursor 
weights are given as an example for polyurethane (PU) 1; Table 1). The flask was maintained at 
80°C and stirred under a nitrogen atmosphere. After the solid contents were melted completely, 
25 mmol of HDI (4.21 g) was added and stirred for 5 min. The sample was allowed to stand in a 
Teflon dish to react for 12 h at 150°C. The synthesized polyurethanes were dissolved in N,N-
dimethylformamide (DMF). After the resulting solution was poured into a large amount of iso-
propyl alcohol, a polymer precipitate was formed and filtered. The product was dried at 40°C for 
72 h under vacuum and stored in a desiccator. PU 2, PU 3, and PU 4 were prepared by similar 
procedures. Polymer yields of 87%, 78%, 71%, and 59% were obtained. The formulation used is 
described in Table 1.
Polymer characterization
1H-nuclear magnetic resonance (NMR) spectrum was recorded for the synthesized polyurethanes 
with a Bruker Avance 600 spectrometer at 600 MHz (Bruker Co., Germany) and performed at ambi-
ent temperature with 5% (w/v) polymer solution in CDCl3. Fourier transform infrared (FT-IR) spec-
tra were obtained at room temperature using a Bio-Rad Excaliber TS-3000MX (Bio-Rad, Tokyo, 
Japan) in the range of 800–4000 cm−1. A 2.5% solution of polymer in chloroform was placed directly 
onto a KBr pellet (Sigma–Aldrich), and the chloroform was evaporated at 50°C under vacuum for 2 
h. The spectra were also checked for evidence of residual solvent.
Molecular weight
The weight average (Mw) and number average (Mn) molecular weights of the polyurethanes were 
measured by gel permeation chromatography (GPC) using a Futecs NP-4000 instrument (Futecs, 
Seoul, South Korea) equipped with a model P-4000 pump, a model AT-4000 column oven, a GPC 
KF-804 column, and a Shodex (Shodex, Tokyo, Japan) R1-101 refractive index detector. 
Table 1. Polyurethanes with different composition contents and their yields.
Polyurethane HDI Isomannide PCL diol (Mw = 2 kDa/mol) Yield (%)
Mole ratio
PU 1 8 3 5 87
PU 2 8 4 4 78
PU 3 8 5 3 71
PU 4 8 6 2 59
HDI: hexamethylene diisocyanate; PCL: poly(ε-caprolactone).
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Tetrahydrofuran (THF) was used as the eluent at a flow rate of 1.0 mL min−1, and a sample concen-
tration of 2.5 mg mL−1 was used. Polystyrene (Mw = 2000, 7000, 12,000, 65,000, and 120,000) was 
used as the standard.
Thermal analysis
Differential scanning calorimetry (DSC) data were recorded with DSC (SEIKO Exstar 7000, 
Tokyo, Japan) instrument. Specimens (approximately 10 mg) were sealed in a DSC aluminum pan 
before being placed in the calorimeter. The samples were cooled to −70°C and then heated to 
250°C at a rate of 10°C min−1 under a nitrogen atmosphere.
Mechanical properties
Following synthesis of the polymer, polymer films for mechanical testing and degradation testing 
were prepared by solvent casting in DMF at 10% polymer concentration into a polytetrafluoroeth-
ylene (PTFE) dish followed by air drying to produce films of 0.2 mm thickness. Tensile strength 
and elongation at break of the polyurethanes were measured on an Instron universal testing machine 
(Model 3344; Instron Engineering Corp., Canton, MA, USA) at a crosshead speed of 10 mm min−1 
at room temperature. The specimens were prepared with a dog bone–shaped cutter. The thickness 
and width of the specimens were 0.2 and 5 mm, respectively. The length of the sample between the 
grips of the testing machine was 15 mm. Five specimen measurements were conducted for each 
polyurethane, and the results were averaged to obtain a mean and standard deviation.
Contact angle and surface energy
The wetting ability of the polymer surface was evaluated based on contact angle measurements 
using a Phoenix 300 contact angle equipment (SEO, Seoul, South Korea). Tests were carried out 
using the sessile drop mode with ultrapure water, which was used to represent polar characteristics. 
Approximately 5 µL droplets of the test liquid were placed on polymer specimens using a manual 
syringe. The drop profile was then recorded at an interval of 1 s for 1 min, and the measurements 
were carried out on triplicate samples. The contact angle values were evaluated using Phoenix 300 
software. The polyurethane series was dried for 24 h prior to contact angle measurement. The cal-
culation of the surface energy was conducted using the Girifalco–Good–Fowkes–Young method 
and Phoenix software.
In vitro degradation test
Polyurethane film (Φ = 12 mm) degradation was quantified by the changes in dry weight. The 
polyurethane samples were allowed to degrade for 2, 4, and 8 weeks. Dry films were weighed (w0) 
and immersed in a conical tube containing 10 mL phosphate-buffered solution (approximately pH 
= 7.3). The degradation was conducted at 37°C ± 1.5°C in a water bath (WB-6; DAIHAN Scientific 
Co., Ltd, Seoul, South Korea). Samples were taken at intervals, rinsed with water, dried in a vac-
uum oven for 2 days at 50°C, and weighed (wt), after which they were discarded. The weight 
remaining was calculated as 
Weight remaining (%) = (w0–wt/w0) × 100
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Cell culture
The polyurethane films were sterilized by soaking in 50%, 70%, and 100% ethanol for 30 min prior 
to use, and then they were dried for 2 h. MC3T3-E1 cells were maintained in standard T75 tissue 
culture flasks in normal growth medium composed of alpha-modified minimum essential medium 
(α-MEM) (Invitrogen, Paisley, UK) supplemented with 10% fetal bovine serum (Gibco, Daejeon, 
South Korea) and 1% penicillin/streptomycin (Gibco). Prior to cell seeding, sections were cut from 
the synthesized polyurethane films, placed into 96-well plates, and seeded with 5 × 103 cells sus-
pended in 1 mL normal growth medium and maintained at 37°C with 5% CO2 for a subsequent 
time course analysis of cell number.
Cell proliferation
Cells were cultured on the polyurethane films (n = 3) (the films were held down in the culture 
plates with PTFE inserts) in 96-well plates for 1, 3, and 7 days. Cell proliferation was determined 
at these time periods using the cell counting kit-8 (CCK-8) (2-(methoxy-4-nitrophenyl)-3-(4-
nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) assay, according to the 
manufacturer’s instructions (CCK-8; Dojindo Laboratories, Kumamoto, Japan). The cells were 
then incubated for 1, 3, and 7 days, and the cell numbers were measured using the CCK-8 reagent. 
The CCK-8 solution was freshly prepared in growth medium, and 200 µL of CCK-8 reagent was 
added to each well, followed by incubation in a humidified atmosphere with 5% CO2. Absorbance 
was measured at 450 nm using a spectrophotometer (Bio-Rad, Seoul, South Korea). A blank exper-
iment to detect cell-free background absorbance was also performed in parallel. Results are 
expressed as relative CCK-8 activity compared to control conditions (cell-free background 
absorbance).
Results
A family of biocompatible and biodegradable polyurethanes was synthesized by a simple one-pot 
polymerization of PCL diol (Mw = 2000) and isomannide, as shown in Scheme 1. The reaction was 
carried out without a catalyst or solvent, which are usually required, in order to decrease potential 
toxicity.13 The chemical structures of the polyurethanes obtained were characterized by 1H-NMR 
and FT-IR spectroscopy.
Figure 1 displays the 1H-NMR spectrum of polyurethane in CDCl3, in which all proton signals 
of isomannide, PCL diol 2000, and HDI segments were confirmed. The signals occurring from 3.5 
to 5.2 were assigned to methylene protons of isomannide. In addition, the peak at 3.1 parts per mil-
lion (ppm) was assigned to the amine proton of the urethane linkage.
In the FT-IR spectra, the complete disappearance of the isocyanate peaks in the polyurethane 
samples occurred at 2250 cm−1 (Figure 2),14 indicating that no unreacted isocyanate groups were 
present in the polyurethane samples. After polymerization, the –OH peaks in the area around 
3446–3558 and 3427 cm−1 of PCL diol and isomannide, respectively, disappeared. A new peak 
at 1529 cm−1 appeared, which was caused by the amide (N–H) bending vibration of the polyure-
thanes. The FT-IR spectrum confirmed that the polyurethane structures had a pronounced free 
amide group (–NH–) peak at 3322 cm−1, and hydrogen-bonded NH stretching bands were seen 
at 1529 cm−1,15 and a carbonyl group (C=O) stretching transmittance at 1721 cm−1. Methylene 
group polymer chains were represented by peaks between 2938 and 2860 cm−1 in the polyure-
thanes and PCL diol. C-H bending and C-O stretching vibration bands were seen in the area from 
1500 to 600 cm−1.
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Molecular weights and thermal properties
The thermal properties and molecular weights of the polyurethanes are listed in Table 2. The weight 
average molecular weights (Mw) ranged from 16,892 to 145,070. Polyurethanes with the higher 
levels of isomannide yielded lower Mw compared to polyurethanes with low levels of isomannide 
may be due to the presence of a secondary hydroxyl group, which is lower in reactivity compared 
to the primary hydroxyl group12 of the PCL diol. It is important to understand the thermal behavior 
of polymers developed for biomedical applications, as it determines the physical properties of the 
materials and the processability. The DSC data of the synthesized polyurethane series are listed in 
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Scheme 1. Synthetic of the route and structure of the polyurethane series.
PCL: poly(ε-caprolactone).
Figure 1. 1H-nuclear magnetic resonance (NMR) spectra of polyurethane.
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Table 2. Only one Tg was detected for all samples. The values of Tg of PU 1, PU 2, PU 3, and PU 
4 were 32°C, 30.9°C, 26.4°C, and 25.3°C, respectively. A melting peak was not observed for any 
of the polymers examined.
Mechanical properties
The ultimate tensile strength (UTS) and Young’s modulus for the polyurethanes are shown in 
Figure 3. The higher molecular weight polyurethane was obtained with PU 1, and this produced a 
Table 2. Molecular weights, thermal properties, and surface energy of the synthesized polyurethanes.
Mw
a
(kDa)/mol Mn
b(kDa)/mol PDIc Tg (°C)d Water (°)e Surface energy (mN m−1)
PU 1 145.0 101.8 1.4257 32.00 ± 0.32 61.34 ± 1.48 49.19 ± 1.50
PU 2   68.2 44.6 1.5284 30.90 ± 0.21 60.67 ± 0.84 49.71 ± 1.13
PU 3   30.8 20.2 1.5242 26.43 ± 0.45 60.44 ± 0.63 50.10 ± 0.64
PU 4   16.9 12.6 1.2960 25.30 ± 0.22 58.00 ± 0.52 52.59 ± 0.53
PDI: polydispersity index.
aThe weight average molecular weights.
bThe number average molecular weights.
cPDI = Mw/Mn.
dGlass transition temperature.
eWater contact angle.
Figure 2. Fourier transform infrared (FT-IR) spectra of (a) isomannide, (b) polyurethane, (c) HDI, and (d) 
PCL diol 2000.
HDI: hexamethylene diisocyanate; PCL: poly(ε-caprolactone).
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mean stiffness (called Young’s modulus) of 27.19 ± 0.5 MPa, which was similar to that of ethyl-
ene–methyl acrylate. The UTS was 20.4 ± 1.09 MPa. Lower molecular weight polyurethane was 
obtained with PU 4, and this produced a mean stiffness of 50.19 ± 5.7 MPa and a UTS of 6.12 ± 
1.00 MPa.
In vitro degradation test
The degradation characteristics of the polyurethane series were studied in vitro using a phosphate 
buffer solution at 37°C. Degradation profiles of the polyurethanes are presented in Figure 4 with 
the percentage weight loss of the polymers with time. It is evident that the polyurethane series was 
undergoing slow degradation. The changes in the polyurethane film surface after degradation 
(Figure 5) were determined by scanning electron microscope (SEM) (model JSM-6510; JEOL, 
Tokyo, Japan) photographs. All surfaces appear relatively smooth initially with a few defects. 
However, all of the polyurethanes had ~7% weight lost over 2 weeks. A continual slow weight loss 
of ~12% was observed for all of polyurethanes between weeks 2 and 8.
CCK-8 assay
The results of CCK-8 absorbance values for MC3T3-E1 cells (CCK-8) adhesion to and prolifera-
tion on the polyurethane films compared to that of PCL are shown in Figure 6. The CCK-8 assay 
Figure 3. (a) Ultimate tensile strength (UTS), (b) Young’s modulus, (c) strain at breaking (%), and (d) 
example of tensile stress–strain curves for the polyurethane series.
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was implemented to measure mesenchymal stem cell (MSC) growth, and as it is specific to viable 
cells, it reflects not only the ability of the polyurethane film to promote cell adhesion and prolif-
eration, but also its cytotoxicity. In comparison with PCL (Mw = 60,000, Sigma–Aldrich), relative 
cell numbers on the polymer films between days 1 and 7 of culturing on polyurethane films pro-
liferated at least as well as those on PCL. Lower cell viability was observed from 1 to 7 days on 
the polyurethane surfaces in comparison with that of the control.
Cell attachment
Attachment of cells to a material is one of the prerequisites for evaluating biocompatibility for pos-
sible utilization in biomedical applications. The morphology of MC3T3-E1 cells after they were 
cultured on the polyurethane polymer films for 1–7 days was examined by SEM. The morphology 
of MC3T3-E1 cells attached to the wells were exhibited in Figure 7. The polyurethane films pro-
vided a suitable environment for cell attachment and spreading. The SEM images of the MC3T3-E1 
cell morphology after being cultured on polyurethane film during 7 days PU 1, PU 2, PU 3, and PU 
4 are shown in Figure 7(a) to (d), respectively. The cell culture results indicate that these polyure-
thanes are biocompatible and nontoxic.
Discussion
A great deal of research over the last decade has been conducted to develop biodegradable polyu-
rethanes for medical applications.1,2 It would be advantageous for some applications if implants 
were produced from biodegradable and/or bioresorbable materials. Continuous degradation of the 
Figure 4. Residual weight (%) of the polyurethane films after degradation in phosphate buffer solution: (a) 
PU 1, (b) PU 2, (c) PU 3, and PU 4.
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Figure 5. (a and b) SEM of PU 1 prior to degradation and at 2 months, (c and d) SEM of PU 2 prior to 
degradation and at 2 months, (e and f) SEM of PU 3 prior to degradation and at 2 months, and (g and f) 
SEM of PU 4 prior to degradation and at 2 months.
SEM: scanning electron microscope.
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implant material may then be accompanied by the formation of new organs and/or tissues.16 
Biodegradable polyurethane elastomers are promising materials for such implants.17
The goal of this study was to evaluate the cytocompatibility of experimental polyurethanes with 
different isomannide-to-PCL diol content ratios in MC3T3-E1 cells. Our one-pot polymerization 
process is very simple and reduces the risk of toxicity from a surfactant or catalyst. In the molecu-
lar weight study, we should consider the reactivity of isomannide. Isomannide may have lower 
reactivity. The effect of the lower reactivity secondary hydroxyl of isomannide appeared to be quite 
evident with PU 1, which had the lowest isomannide content, and showed the highest Mw. This was 
also supported by the polymer yield data. The variations in the Tg of the soft segment as a function 
of composition have been suggested as an indicator of the degree of microphase separation in ther-
moplastic polyurethane elastomers.18 In general, the Tg value of soft segments decreases with 
increasing soft-segment molecular weight and decreasing diisocyanate content, although the 
changes are quite small. The Tg value also increased with increasing molecular weight.19 Factors 
with an effect on Tg in polyurethanes based on aliphatic diisocyanate include crystallization of the 
soft-segment and hard-segment components, the steric hindrance of the hard-segment unit during 
hydrogen bonding, and the inherent solubility of the hard and soft components.20 If the Tg value is 
above body temperature, material will be in a rigid state.21 On the other hand, if the Tg of the poly-
mer is below body temperature, the material would be in a rubbery state. For the polyurethanes in 
this study, the Tg decreased with decreasing molecular weight and Tg increased with decreasing 
contents of isomannide as expected. All four polyurethanes had a Tg below body temperature; thus, 
these polyurethanes could exhibit elastomeric properties at body temperature. Elastomeric 
Figure 6. CCK-8 assay of rat MC3T3-E1 cultured on polyurethane wells showed more metabolically 
active cells on polyurethanes during the first 7 days.
ANOVA: analysis of variance; CCK: cell counting kit; PCL: poly(ε-caprolactone).
Data are mean ± standard deviation. Significantly different from the control (*p < 0.05, **p < 0.01, ANOVA, n = 3). 
Normalized values are shown.
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Figure 7. SEM images illustrating morphology of MC3T3-E1 cells after being cultured on polyurethane 
film during 7 days (a) PU 1, (b) PU 2, (c) PU 3, and (d) PU 4.
SEM: scanning electron microscope.
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properties at body temperature are an important quality for polymers in soft tissue engineering.21 
The polyurethane films were flexible with tensile strengths from 6.12 ± 1.0 to 20.40 ± 1.09 MPa, 
stiffness from 27.2 ± 0.51 to 50.19 ± 5.7 MPa, and breaking strains from 208% to 1239%. The UTS 
of the films was comparable to that of the aorta (50%–100%),21 whereas the breaking strains were 
generally greater than that of the aorta. The mechanical properties of the film depended on the 
molecular weight, hard segments, and soft segments. As the molecular weight of a polymer 
increases, tensile strength increased. In addition, there was a relationship between hard segment 
and stiffness.22 The polyurethane stiffness increased with increasing isomannide (hard segment) 
levels. The main degradable polymers used in biomedicine are PCL, polyglycolic acid (PGA), and 
poly(L-lactic acid) (PLLA) and their derivatives. These polymers are all very stiff and are not suit-
able for utilization for tissue engineering of soft tissues, even in a fibrous or woven state. The 
development of softer, more flexible, and degradable polymers, as shown in this study, opens up a 
range of opportunities for soft tissue augmentation and regeneration, and the polymer family syn-
thesized in this study offers such properties.
Much attention has been paid to the surface properties and structure of polymers, because the 
functional groups on the surface play an important role in the interactions of the materials with 
cells.23 Contact angles have been used to estimate surface properties. The measured contact angles 
are listed in Table 2, and all of the polyurethane water contact angles were <61°. It is generally 
agreed that hydrophilic surfaces have a contact angle with water in the range of 1°–30°, whereas 
hydrophobic surfaces have contact angles of >90°. Therefore, our polyurethanes had values some-
where between these ranges. As the isomannide content, which is a hydrophilic unit monomer, 
increased, the water contact angle of the polyurethanes decreased, indicating that the hydrophilic-
ity of the polyurethanes can be controlled, although the changes were relatively small.
The rate of degradation of polyurethanes in aqueous media by hydrolysis is controlled mainly 
by the presence of urethane and ester bonds and varies significantly with the polymer chemical 
structure.24 The acidic carboxyl group accelerates the hydrolysis of the polyester segments.18 The 
biodegradability of polyurethanes also depends on the molecular weight, degree of crystallinity, 
chemical structure, as well as susceptibility to microbial attack.26 The number of carbons in the 
dialcohol seems to play an important role during hydrolytic degradation. The isomannide gives 
higher hydrophilicity to the polyurethane segment than does PCL diol, making hydrolytic attack 
easier. The rate of hydrophilicity and hard-segment contents had a more dominant effect on bio-
degradation rate rather than crystallinity for the polyurethanes presented here.25
Many studies have ascertained biocompatibility using the CCK-8 or 3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay.18 When cell prolifera-
tion on a polymer is maintained for 1–2 weeks,26 then the polymer can be considered cytocompatible 
and biocompatible. MC3T3-E1 cells were used as they are highly sensitive to culture conditions. The 
cell number was assessed via the CCK-8 assay due to its reliability and sensitivity.27 The cells showed 
lower numbers from 1 to 7 days compared with the control, when seeded on polyurethane surfaces 
(Figure 7); however, the cells began to proliferate and increase in number. In comparison with PCL, 
relative cell number on polyurethane films in 7 days of culture was approximately the same as PCL. 
Although the cells showed a lower rate of proliferation than that of the control, the polyurethane films 
were considered to be cytocompatible. Furthermore, the synthesized polyurethanes had good 
mechanical strength, thermal stability, cytocompatibility, and biodegradability.
Conclusion
Polyurethane biobased isomannide polymers were synthesized from HDI via a simple one-pot 
polymerization. The important advantage was not to require a catalyst, solvent, or surfactant during 
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the reaction, which offered clinical advantages related to toxicity. Based on the in vitro mouse 
osteoblast cultures, the cells were suppressed slightly compared to the control but they grew well 
on the polyurethane films for 5 days. The CCK-8 cytotoxicity assay indicated that the polyure-
thanes had good biocompatibility. Taking into account the biocompatibility, degradability, and 
mechanical properties, these biobased polyurethanes have potential for soft tissue reconstruction, 
such as bladder, tracheal, and cardiovascular applications.
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